2018 Q1 Form 10-Q Financial Statement

#000114420418027120 Filed on May 10, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $1.544M $1.211M
YoY Change 27.49% 332592.31%
Cost Of Revenue $1.367M $1.062M
YoY Change 28.71% 76.11%
Gross Profit $177.1K $149.0K
YoY Change 18.88% -62443.1%
Gross Profit Margin 11.47% 12.3%
Selling, General & Admin $3.199M $2.266M
YoY Change 41.18% 12.59%
% of Gross Profit 1806.25% 1520.93%
Research & Development $2.056M $1.669M
YoY Change 23.18% 30.93%
% of Gross Profit 1160.64% 1120.1%
Depreciation & Amortization $270.0K $310.0K
YoY Change -12.9% 29.17%
% of Gross Profit 152.43% 208.05%
Operating Expenses $5.529M $4.175M
YoY Change 32.43% 20.78%
Operating Profit -$5.352M -$4.026M
YoY Change 32.92% 8.94%
Interest Expense $9.213K $40.97K
YoY Change -77.51% 22.1%
% of Operating Profit
Other Income/Expense, Net -$14.04K -$155.6K
YoY Change -90.98% 94.78%
Pretax Income -$5.366M -$4.182M
YoY Change 28.31% 10.75%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.366M -$4.182M
YoY Change 28.3% 110652.12%
Net Earnings / Revenue -347.54% -345.33%
Basic Earnings Per Share
Diluted Earnings Per Share -$198.4K -$206.3K
COMMON SHARES
Basic Shares Outstanding 27.30M shares 20.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.10M $10.40M
YoY Change 247.12% 26.83%
Cash & Equivalents $36.07M $10.40M
Short-Term Investments
Other Short-Term Assets $600.0K $800.0K
YoY Change -25.0% 0.0%
Inventory $4.300M $2.700M
Prepaid Expenses
Receivables $1.100M $300.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $42.00M $14.20M
YoY Change 195.77% 13.6%
LONG-TERM ASSETS
Property, Plant & Equipment $4.179M $3.413M
YoY Change 22.43% 48.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.800M $4.100M
YoY Change 41.46% 28.13%
TOTAL ASSETS
Total Short-Term Assets $42.00M $14.20M
Total Long-Term Assets $5.800M $4.100M
Total Assets $47.80M $18.30M
YoY Change 161.2% 16.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.700M $1.000M
YoY Change 70.0% 150.0%
Accrued Expenses $1.076M $1.200M
YoY Change -10.34% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K
YoY Change 400.0%
Total Short-Term Liabilities $3.182M $3.200M
YoY Change -0.58% 128.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $200.0K
YoY Change -50.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.182M $3.200M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.182M $3.400M
YoY Change -6.43% 9.68%
SHAREHOLDERS EQUITY
Retained Earnings -$96.39M
YoY Change
Common Stock $27.31K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.58M $14.90M
YoY Change
Total Liabilities & Shareholders Equity $47.77M $18.30M
YoY Change 161.02% 16.56%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$5.366M -$4.182M
YoY Change 28.3% 110652.12%
Depreciation, Depletion And Amortization $270.0K $310.0K
YoY Change -12.9% 29.17%
Cash From Operating Activities -$6.471M -$3.833M
YoY Change 68.81% 19.32%
INVESTING ACTIVITIES
Capital Expenditures $306.7K $262.8K
YoY Change 16.73% -36.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$415.2K -$305.1K
YoY Change 36.08% -31.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $30.00M $0.00
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities 28.06M $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -6.471M -$3.833M
Cash From Investing Activities -415.2K -$305.1K
Cash From Financing Activities 28.06M $0.00
Net Change In Cash 21.18M -$4.138M
YoY Change -611.76% 12.97%
FREE CASH FLOW
Cash From Operating Activities -$6.471M -$3.833M
Capital Expenditures $306.7K $262.8K
Free Cash Flow -$6.778M -$4.096M
YoY Change 65.47% 13.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1075932 USD
CY2018Q1 us-gaap Liabilities
Liabilities
3181536 USD
CY2017Q4 us-gaap Liabilities
Liabilities
5453540 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47766398 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26833253 USD
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
50 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
50 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
27307 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
24276 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
146313883 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
117827839 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
44584862 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21379713 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101756378 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96472452 USD
CY2018Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
452473 USD
CY2017Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
408723 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
107824 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1235183 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1665229 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
239830 USD
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
273622 USD
CY2017Q1 us-gaap Taxes Other
TaxesOther
10550 USD
CY2018Q1 us-gaap Taxes Other
TaxesOther
28542 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4181812 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5365650 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-5365650 USD
CY2018Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
438836 USD
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1097 USD
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4418 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-155604 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14040 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5351610 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4026208 USD
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
17900 USD
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2017Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
73462 USD
CY2018Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
210640 USD
CY2017Q4 vuzi Prepaid Manufacturing Vendor Payments
PrepaidManufacturingVendorPayments
154717 USD
CY2018Q1 vuzi Prepaid Manufacturing Vendor Payments
PrepaidManufacturingVendorPayments
126059 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1389771 USD
CY2018Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
22751 USD
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3500 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3181536 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5453540 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4178799 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4124466 USD
CY2017Q4 vuzi Accrued Revenuecurrent
AccruedRevenuecurrent
497784 USD
CY2018Q1 vuzi Accrued Revenuecurrent
AccruedRevenuecurrent
0 USD
CY2018Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
124794 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
152927 USD
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
959383 USD
CY2018Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1363379 USD
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
251280 USD
CY2018Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
180516 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1210663 USD
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1543895 USD
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
953903 USD
CY2018Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1182215 USD
CY2017Q1 us-gaap Cost Of Services
CostOfServices
108000 USD
CY2018Q1 us-gaap Cost Of Services
CostOfServices
184555 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
1061903 USD
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
1366770 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
148760 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
177125 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1668956 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2055787 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1030999 USD
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1534097 USD
CY2018Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
28133 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2018Q1 us-gaap Interest Expense
InterestExpense
9213 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5804486 USD
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26296188 shares
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
424700 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
77165 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
217261 USD
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
424013 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
69614 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-277615 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-246687 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1978637 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-82323 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-211052 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
49262 USD
CY2018Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
137178 USD
CY2017Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
42123 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
19251 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1169 USD
CY2018Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10787 USD
CY2017Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
40926 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6470978 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3833199 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
306739 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
262774 USD
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
64664 USD
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
42315 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-415153 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-305089 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28064375 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21178244 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4138288 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14533944 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10395656 USD
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
19999 USD
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
10690 USD
CY2017Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2018Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
83751 USD
CY2017Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
71613 USD
CY2018Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-211399 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-26100 USD
CY2017Q1 vuzi Increase Decrease In Vendors Prepayments
IncreaseDecreaseInVendorsPrepayments
68111 USD
CY2018Q1 vuzi Increase Decrease In Vendors Prepayments
IncreaseDecreaseInVendorsPrepayments
-28658 USD
CY2017Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1197341 USD
CY2018Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-25110 USD
CY2018Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-92000 USD
CY2018Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
28133 USD
CY2017Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
22560 USD
CY2018Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2017Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
145645 USD
CY2018Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
43750 USD
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0 USD
CY2018Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
39375 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2018Q1 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
8,800,821
CY2017Q1 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
6,446,784
CY2018Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
2078104 USD
CY2017Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
1669209 USD
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7179 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
25090 USD
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3410879 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2994342 USD
CY2018Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1219832 USD
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
836324 USD
CY2018Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
259910 USD
CY2017Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
163305 USD
CY2018Q1 vuzi Accrued Compensation
AccruedCompensation
235469 USD
CY2017Q4 vuzi Accrued Compensation
AccruedCompensation
327469 USD
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
185400 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
531728 USD
CY2018Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
198016 USD
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
167503 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28331 USD
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36488 USD
CY2017Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
171435 USD
CY2018Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
160649 USD
CY2018Q1 vuzi Officers Compensation Payable Compounding Monthly Interest Rate
OfficersCompensationPayableCompoundingMonthlyInterestRate
0.08 pure
CY2018Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
198016 USD
CY2018Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
92547 USD
CY2018Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
123060 USD
CY2018Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
38100 shares
CY2018Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
124794 USD
CY2018Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
124794 USD
CY2017Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
152927 USD
CY2017Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
152927 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-28133 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
124794 USD
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
49626 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
49626 shares
CY2018Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5287899 USD
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4849063 USD
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27307455 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24276275 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1184912 shares
CY2018Q1 vuzi Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
27500 shares
CY2018Q1 vuzi Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
1200000 shares
CY2018Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2357412 shares
CY2018Q1 vuzi Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
0 shares
CY2018Q1 vuzi Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms
P1Y10M6D
CY2018Q1 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
8.29
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
850721 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.55
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
630088 shares
CY2018Q1 vuzi Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
5.57
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P8Y8M12D
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3130000 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1177260 USD
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
9119 USD
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
332932 USD
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
443910 USD
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
383483 USD
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
7816 USD
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
112896 USD
CY2017Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
110369 USD
CY2018Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 34.55pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Note&#160;1&#160;&#151; Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (&#8220;the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2017 was derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017 (the &#8220;Annual Report&#8221;).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2017, as reported in the Company&#8217;s Annual Report.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The results of the Company&#8217;s operations for any interim period are not necessarily indicative of the results of the Company&#8217;s operations for any other interim period or for a full fiscal year.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> For the three months ended March 31, 2018, Toshiba Japan represented <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 94</font>% of engineering revenues and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>% of total revenues as compared to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 96</font>%&#160;and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>%, respectively, in the comparable 2017 period. As of March 31, 2018 and 2017, Toshiba Japan accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% of accounts receivables and accrued project revenue, respectively.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
167503 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
152927 USD
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
49626 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
49626 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27307455 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24276275 shares
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
246488 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
243717 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
5528735 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4174968 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q1 vuzi Increasedecrease In Accrued Revenue
IncreasedecreaseInAccruedRevenue
-497784 USD
CY2017Q1 vuzi Increasedecrease In Accrued Revenue
IncreasedecreaseInAccruedRevenue
0 USD
CY2018Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1975000 USD
CY2017Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2017Q1 vuzi Reclassification Of Derivative Liability To Paidin Capital Upon Waiver Of Certain Antidilutive Provisions Of Warrants And Convertible Debt
ReclassificationOfDerivativeLiabilityToPaidinCapitalUponWaiverOfCertainAntidilutiveProvisionsOfWarrantsAndConvertibleDebt
14820 USD
CY2018Q1 vuzi Cumulative Revenue Adjustment
CumulativeRevenueAdjustment
81724 USD
CY2018Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
81724 USD
CY2018Q1 vuzi Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
39375 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
424700 USD
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30000000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1975000 USD
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.00
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
28025000 USD
CY2017Q4 us-gaap Deferred Revenue
DeferredRevenue
81724 USD
CY2018Q1 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-81724 USD
CY2018Q1 us-gaap Deferred Revenue
DeferredRevenue
0 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96472452 USD
CY2018Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
81724 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96390728 USD
CY2018Q1 vuzi Revenue Performance Obligation Percentage
RevenuePerformanceObligationPercentage
1 pure
CY2018Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
944000 USD
CY2018Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
145645 USD
CY2017Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
38100 shares
CY2017Q1 vuzi Cumulative Revenue Adjustment
CumulativeRevenueAdjustment
0 USD
CY2018Q1 vuzi Reclassification Of Derivative Liability To Paidin Capital Upon Waiver Of Certain Antidilutive Provisions Of Warrants And Convertible Debt
ReclassificationOfDerivativeLiabilityToPaidinCapitalUponWaiverOfCertainAntidilutiveProvisionsOfWarrantsAndConvertibleDebt
0 USD
CY2018Q1 us-gaap Gain Contingency Description
GainContingencyDescription
We filed a defamation lawsuit against Ricardo Antonio Pearson (a\k\a Richard Pearson) in the Supreme Court of the State of New York, County of New York on April 5, 2018. The Company&#8217;s complaint against Mr. Pearson alleges he published false and defamatory articles about the Company. Vuzix is seeking damages in excess of $80 million, including punitive damages, and money damages.
CY2018Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1200000 shares

Files In Submission

Name View Source Status
0001144204-18-027120-index-headers.html Edgar Link pending
0001144204-18-027120-index.html Edgar Link pending
0001144204-18-027120.txt Edgar Link pending
0001144204-18-027120-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv493079_10q.htm Edgar Link pending
tv493079_ex31-1.htm Edgar Link pending
tv493079_ex31-2.htm Edgar Link pending
tv493079_ex32-1.htm Edgar Link pending
tv493079_ex32-2.htm Edgar Link pending
vuzi-20180331.xml Edgar Link completed
vuzi-20180331.xsd Edgar Link pending
vuzi-20180331_cal.xml Edgar Link unprocessable
vuzi-20180331_def.xml Edgar Link unprocessable
vuzi-20180331_lab.xml Edgar Link unprocessable
vuzi-20180331_pre.xml Edgar Link unprocessable